Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Ramiven 150mg Tablet (Abemaciclib)
Ramiven 150mg Tablet, containing Abemaciclib, is an anti-cancer medication prescribed for the treatment of metastatic breast cancer. It is designed to slow down the growth of cancer cells and potentially lead to their elimination, thereby alleviating symptoms associated with breast cancer such as breast lumps, nipple discharge, or changes in breast shape.
Uses of Ramiven 150mg Tablet
Ramiven 150mg Tablet is used specifically for the treatment of metastatic breast cancer, often in combination with other medications to enhance therapeutic efficacy.
Benefits of Ramiven 150mg Tablet
This medication offers the benefit of potentially reducing the progression of metastatic breast cancer, improving quality of life, and prolonging survival when used according to prescribed guidelines.
Mechanism of Action of Ramiven 150mg Tablet
Ramiven 150mg Tablet works by inhibiting specific enzymes called cyclin-dependent kinases (CDK4 and CDK6), which play a crucial role in the growth and division of cancer cells. By blocking these enzymes, the medication helps to arrest the proliferation of cancer cells and may induce their death.